Literature DB >> 19841311

Toward efficient trials in colorectal cancer: the ARCAD Clinical Trials Program.

Aimery de Gramont1, Daniel G Haller, Daniel J Sargent, Josep Tabernero, Alastair Matheson, Richard L Schilsky.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19841311     DOI： 10.1200/JCO.2009.25.2544

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

1.  The ARCAD clinical trials program: an update and invitation.

Authors:  Daniel J Sargent; Marc Buyse; Alastair Matheson; Richard M Goldberg; Aimery de Gramont
Journal:  Oncologist       Date:  2012-02-02

2.  Simplified prognostic model in patients with oxaliplatin-based or irinotecan-based first-line chemotherapy for metastatic colorectal cancer: a GERCOR study.

Authors:  Benoist Chibaudel; Franck Bonnetain; Christophe Tournigand; Leila Bengrine-Lefevre; Luis Teixeira; Pascal Artru; Jérôme Desramé; Annette K Larsen; Thierry André; Christophe Louvet; Aimery de Gramont
Journal:  Oncologist       Date:  2011-08-22

3.  Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project.

Authors:  Katrin M Sjoquist; Lindsay A Renfro; R John Simes; Niall C Tebbutt; Stephen Clarke; Matthew T Seymour; Richard Adams; Timothy S Maughan; Leonard Saltz; Richard M Goldberg; Hans-Joachim Schmoll; Eric Van Cutsem; Jean-Yves Douillard; Paulo M Hoff; Joel Randolph Hecht; Christophe Tournigand; Cornelis J A Punt; Miriam Koopman; Herbert Hurwitz; Volker Heinemann; Alfredo Falcone; Rainer Porschen; Charles Fuchs; Eduardo Diaz-Rubio; Enrique Aranda; Carsten Bokemeyer; Ioannis Souglakos; Fairooz F Kabbinavar; Benoist Chibaudel; Jeffrey P Meyers; Daniel J Sargent; Aimery de Gramont; John R Zalcberg
Journal:  J Natl Cancer Inst       Date:  2018-06-01       Impact factor: 13.506

4.  Body Mass Index Is Prognostic in Metastatic Colorectal Cancer: Pooled Analysis of Patients From First-Line Clinical Trials in the ARCAD Database.

Authors:  Lindsay A Renfro; Fotios Loupakis; Richard A Adams; Matthew T Seymour; Volker Heinemann; Hans-Joachim Schmoll; Jean-Yves Douillard; Herbert Hurwitz; Charles S Fuchs; Eduardo Diaz-Rubio; Rainer Porschen; Christophe Tournigand; Benoist Chibaudel; Alfredo Falcone; Niall C Tebbutt; Cornelis J A Punt; J Randolph Hecht; Carsten Bokemeyer; Eric Van Cutsem; Richard M Goldberg; Leonard B Saltz; Aimery de Gramont; Daniel J Sargent; Heinz-Josef Lenz
Journal:  J Clin Oncol       Date:  2015-10-26       Impact factor: 44.544

5.  Toward a Tiered Model to Share Clinical Trial Data and Samples in Precision Oncology.

Authors:  Stefanie Broes; Denis Lacombe; Michiel Verlinden; Isabelle Huys
Journal:  Front Med (Lausanne)       Date:  2018-01-29

6.  Clinico-pathological nomogram for predicting BRAF mutational status of metastatic colorectal cancer.

Authors:  Fotios Loupakis; Roberto Moretto; Giuseppe Aprile; Marta Muntoni; Chiara Cremolini; Donatella Iacono; Mariaelena Casagrande; Laura Ferrari; Lisa Salvatore; Marta Schirripa; Daniele Rossini; Giovanna De Maglio; Gianpiero Fasola; Lorenzo Calvetti; Sara Pilotto; Luisa Carbognin; Gabriella Fontanini; Giampaolo Tortora; Alfredo Falcone; Isabella Sperduti; Emilio Bria
Journal:  Br J Cancer       Date:  2015-11-17       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.